Is RadNet (RDNT) overvalued or fairly valued?

MarketChacha shows RadNet's valuation in context — a forward P/E of about 63.1, a price-to-book of about 4.2 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is RadNet's revenue?

RadNet reported revenue of $2.0B for FY2025, with net profit of $-18.7M, per official filings.

What is the share price of RadNet (RDNT)?

RadNet last traded at $59.49 (-3.9% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

RadNet

RDNT · NYSE · Healthcare · United States

$59.49-3.9%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:35 PM

Snapshot

TickerRDNT

ExchangeNYSE

SectorHealthcare

IndustryDiagnostics & Research

CountryUnited States

Employees11,000

HeadquartersLos Angeles, United States

Market cap$4.7B

P/B4.2

Volume344.79K

Websitewww.radnet.com

Filings tracked5

About RadNet

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Profile as reported by Yahoo Finance.

Who owns it

Insiders10.0%
Institutions90.0%
Public & other0.0%

456 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.12.76%
RTW Investments LP5.45%
Price (T.Rowe) Associates Inc5.28%
Vanguard Portfolio Management LLC4.96%
Beck, Mack & Oliver LLC4.03%
Vanguard Capital Management LLC3.96%
State Street Corporation3.37%
Geode Capital Management, LLC2.19%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

Latest ROE of -1.7% is on the low side — the business earns a modest return on shareholder capital.

Net margin trend0.2% → -0.9%

Margin has held broadly steady over the period — stable profitability.

Return on equity-1.7%

Latest ROE of -1.7% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $636.2M · EPS 0.26

Est. earnings growth +27.5%

Next fiscal year

Rev $2.7B · EPS 0.94

Est. earnings growth +82.9%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$50.7652-wk range$85.84

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$4.7B

Day change

-3.9%

Fwd P/E

63.1

P/B

4.2

Beta

1.36

Revenue (FY2025)

$2.0B

Net margin

-0.9%

ROE

-1.7%

Revenue CAGR (2y)

+12.3%

EPS (FY2025)

-0.25

Net profit (FY2025)

$-18.7M

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about RDNT

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$2.0B	$-18.7M	-0.25	-0.9%	-1.7%
FY2024	$1.8B	$2.8M	0.04	0.2%	0.3%
FY2023	$1.6B	$3.0M	0.05	0.2%	0.5%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$575.6M	$-33.5M	-0.43	-5.8%
2025Q3	$522.9M	$5.4M	0.07	1.0%
2025Q2	$498.2M	$14.5M	0.19	2.9%
2025Q1	$471.4M	$-37.9M	-0.51	-8.0%
2024Q3	$461.1M	$3.2M	0.04	0.7%
2024Q2	$459.7M	$-3.0M	-0.04	-0.6%
2024Q1	$431.7M	$-2.8M	-0.04	-0.6%
2023Q3	$402.0M	$17.5M	0.25	4.4%
2023Q2	$403.7M	$8.4M	0.12	2.1%
2023Q1	$390.6M	$-21.0M	-0.36	-5.4%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Material agreement, Material financial obligation, Reg FD disclosure, Exhibits
SEC6/10/2026material
8-K — Shareholder vote results
SEC6/4/2026material
8-K — Other events, Exhibits
SEC6/3/2026material
8-K — Results of operations, Exhibits
SEC5/11/2026material
10-Q filing
SEC5/11/2026

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.